Citations for
1F8, F9
Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.
Venkateswarlu D.
Biochem Biophys Res Commun 452(3):408-14. doi: 10.1016/j.bbrc.2014.08.078. 2014
2F9, ONECUT1, ONECUT2
A CpG mutational hotspot in a ONECUT binding site accounts for the prevalent variant of hemophilia B Leyden.
Funnell AP, Wilson MD, Ballester B, Mak KS, Burdach J, Magan N, Pearson RC, Lemaigre FP, Stowell KM, Odom DT, Flicek P, Crossley M.
Am J Hum Genet 92(3):460-7. doi: 10.1016/j.ajhg.2013.02.003. 2013
3F9, F9D
Spectrum of factor IX gene mutations causing haemophilia B from India.
Ghosh K, Quadros L, Shetty S.
Blood Coagul Fibrinolysis lood Coagul Fibrinolysis. 2009 Apr 7. [Epub ahead of print] 2009
4F8, F8D, F9
The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor xase complex.
Soeda T, Nogami K, Nishiya K, Takeyama M, Ogiwara K, Sakata Y, Yoshioka A, Shima M.
J Biol Chem 284(6):3379-88. Epub 2008 Dec 1. 2009
5F9, F9D
Identification of mutations in the F9 gene including exon deletion by multiplex ligation-dependent probe amplification in 33 unrelated Korean patients with haemophilia B.
Kwon MJ, Yoo KY, Kim HJ, Kim SH.
Haemophilia 14(5):1069-75. Epub 2008 Jul 8. 2008
6F9, F9D
Sequence and structural properties of identical mutations with varying phenotypes in human coagulation factor IX.
Chavali S, Sharma A, Tabassum R, Bharadwaj D.
Proteins 73(1):63-71. 2008
7F9
The interface between the EGF2 domain and the protease domain in blood coagulation factor IX contributes to factor VIII binding and factor X activation.
Fribourg C, Meijer AB, Mertens K.
Biochemistry 45(35):10777-85. 2006
8ATP11A, ATP11B, ATP11C, F9, HPT1, RNU7L
X-linked hypoparathyroidism region on Xq27 is evolutionarily conserved with regions on 3q26 and 13q34 and contains a novel P-type ATPase.
Andrew Nesbit M, Bowl MR, Harding B, Schlessinger D, Whyte MP, Thakker RV.
Genomics 84(6):1060-70. 2004
9F9
High levels of factor IX increase the risk of venous thrombosis.
van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR.
Blood 95(12):3678-82. 2000
10F9
Germline origins in the human F9 gene: frequent G:C-->A:T mosaicism and increased mutations with advanced maternal age.
Ketterling RP, Vielhaber E, Li X, Drost J, Schaid DJ, Kasper CK, Phillips JA 3rd, Koerper MA, Kim H, Sexauer C, Gruppo R, Ambriz R, Paredes R, Sommer SS.
Hum Genet 105(6):629-40 1999
11F9, F9D
Missense mutations at ALA-10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy.
Oldenburg J, Quenzel EM, Harbrecht U, Fregin A, Kress W, Muller CR, Hertfelder HJ, Schwaab R, Brackmann HH, Hanfland P.
Br J Haematol 98(1):240-4. 1997
12F9
A mutation in the propeptide of factor IX leads to warfarin sensitivity by a novel mechanism.
Chu K, et al.
J Clin Invest 98 : 1619-1625. 1996
13ADFN, CD40LG, F9, GPC3, HPRT1, HPT1, HTX1, MCF2, THAS
YAC/STS map of 9 Mb of Xq26 at 100-kb resolution, localizing 6 ESTs, 6 genes, and 32 genetic markers.
Pilia G, et al.
Genomics 34 : 55-62. 1996
14ADFN, F9, FRAXA, HPT1, IDS, SOX3, THAS
YAC/STS map across 12 Mb of Xq27 at 25-kb resolution, merging Xq26-qter.
Zucchi I, et al.
Genomics 34 : 42-54. 1996
15F9
The rates and patterns of deletions in the human factor IX gene.
Ketterling RP, et al.
Am J Hum Genet 54 : 201-213. 1994
16F9
Microdeletions in the factor IX gene : three recurrences associated with a quasipalindromic sequence.
Ketterling RP, et al.
Hum Mol Genet 3 : 191-192. 1994
17F9, F9D
A novel mutation (Val-373 to Glu) in the catalytic domain of factor IX, resulting in moderately/severe hemophilia B in a Southern French patient.
Aguilar-Martinez P, et al.
Hum Mutat 3 : 156-158. 1994
18F9
Cryptic dinucleotide polymorphism in the 3' region of the factor IX gene shows substantial variation among different populations.
Sommer SS, et al.
Hum Genet 93 : 357-358. 1994
19F10, F10D, F9, F9D
Five novel point mutations : two causing haemophilia B and three causing factor X deficiency.
Odom MW, et al.
Mol Cell Probes 8 : 63-65. 1994
20F9
Determinants of the factor IX mutational spectrum in haemophilia B : an analysis of missense mutations using a multi-domain molecular model of the activated protein.
Wacey AI, et al.
Hum Genet 94 : 594-608. 1994
21F9, F9D
Haemophilia B due to a De novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene.
Vidaud D, et al.
Eur J Hum Genet 1 : 30-36. 1993
22F9
Factor IX Fukuoka. Substitution of ASN92 by his in the second epidermal growth factor-like domain results in defective interaction with factors VIIIa/X.
Nishimura H, et al.
J Biol Chem 268 : 24041-24046. 1993
23F9
A polymorphic MseI site 5' to the factor IX gene varies among ethnic groups.
Weinmann AF, et al.
Hum Mol Genet 2 : 486. 1993
24F9
Vertical integration of cosmid and YAC resources for interval mapping on the X-chromosome.
Holland J, et al.
Genomics 15 : 297-304. 1993
25F9
Five novel factor IX mutations in unrelated hemophilia B families.
Chen SH, et al.
Hum Mol Genet 2 : 599-600. 1993
26F9
The pattern of spontaneous germ-line mutation : relative rates of mutation at or near CpG dinucleotides in the factor IX gene.
Bottema CDK, et al.
Hum Genet 91 : 496-503. 1993
27F9, F9D
A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B.
Vielhaber E, et al.
Hum Mol Genet 2 : 1309-1310. 1993
28F9, F9D
Hemophilia B Leyden : substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter.
Reijnen MJ, et al.
Blood 82 : 151-158. 1993
29F9, F9D
Haemophilia B : database of point mutations and short additions and deletions (fourth edition, 1993).
Giannelli F, et al.
Nucleic Acids Res 21 : 3075-3087. 1993
30F9
Single-strand conformation polymorphism (SSCP) analysis of the molecular pathology of hemophilia B.
David D, et al.
Hum Mutat 2 : 355-361. 1993
31F9
Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation.
Ketterling RP, et al.
Am J Hum Genet 52 : 152-166. 1993
32HPRT1, F9
Yeast artificial chromosomes spanning 8 megabases and 10-15 centimorgans of human cytogenetic band Xq26.
Little RD, et al.
Proc Natl Acad Sci U S A 89 : 177-181. 1992
33F9
Parental origin of factor IX gene mutations, and their distribution in the gene.
Ludwig M, et al.
Am J Hum Genet 50 : 164-173. 1992
34F9
Factor IX(Madrid 2) : a deletion/insertion in factor IX gene which abolishes the sequence of the donor junction at the exon iv-intron d splice site.
Solera J, et al.
Am J Hum Genet 50 : 434-437. 1992
35F9
An A to T transversion at position -5 of the factor IX promoter results in hemophilia B.
Picketts DJ, et al.
Genomics 12 : 161-163. 1992
36F9
Hemophilia B caused by five different nondeletion mutations in protease domain of factor IX.
Ludwig M, et al.
Blood 79 : 1225-1232. 1992
37F9
Identification of factor IX mutations in haemophilia B : application of polymerase chain reaction and single strand conformation analysis.
Fraser BM, et al.
Hum Genet 88 : 426-430. 1992
38F9
Somatic mosaicism and female-to-female transmission in a kindred with hemophilia B (factor IX deficiency).
Taylor SAM, et al.
Proc Natl Acad Sci U S A 88 : 39-42. 1991
39F9
CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in the hemophilia B patients: a Seattle series.
Chen SH, et al.
Hum Genet 87 : 177-182. 1991
40F9
Factor IX Amagasaki : a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities.
Miyata T, et al.
Biochemistry 30 : 11286-11291. 1991
41F9
Factor IX(Basel) : a Swiss family with severe haemophilia B, having a point mutation in EGF type B domain.
Alkan M, et al.
Nucleic Acids Res 19 : 409. 1991
42F9
Identification of haemophilia B patients with mutations in the two calcium binding domains of factor IX : importance of a beta-OH Asp 64-Asn change.
Winship PR, et al.
Br J Haematol 77 : 102-109. 1991
43F9
The varying frequencies of five DNA polymorphisms of X-linked coagulant factor IX in eight ethnic groups.
Graham JB, et al.
Am J Hum Genet 49 : 537-544. 1991
44F9
Polymerase chain reaction detection of the Dde I polymorphism in the factor 9 gene for fragile X linkage analysis.
Dobkin CS, et al.
Am J Med Genet 38 : 378-379. 1991
45F9
Facile and rapid analysis of three DNA polymorphisms within the human factor IX gene using the polymerase chain reaction.
Bowen DJ, et al.
Br J Haematol 77 : 559-560. 1991
46F9, IDS
Genetic mapping of new RFLPs at Xq27-q28.
Suthers GK, et al.
Genomics 9 : 37-43. 1991
47F9
Missense mutations and evolutionary conservation of amino acids : evidence that many of the amino acids in factor IX function as spacer elements.
Bottema CDK, et al.
Am J Hum Genet 49 : 820-838. 1991
48F9
Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B.
Crossley M, et al.
Nature 345 : 444-446. 1990
49F9
Haemophilia B: database of point mutations and short additions and deletions.
Giannelli F, et al.
Nucleic Acids Res 18 : 4053-4059. 1990
50F9
Recombination between two 14-bp homologous sequences as the mechanism for gene deletion in factor IX (Seattle I).
Chen SH, et al.
Am J Hum Genet 47 : 1020-1022. 1990
51F9
Recurrent nonsense mutations at arginine residues cause severe hemophilia B in unrelated hemophiliacs.
Koeberl DD, et al.
Hum Genet 84 : 387-390. 1990
52F9
Two factor IX mutations in the family of an isolated haemophilia B patient : direct carrier diagnosis by amplification mismatch detection (AMD).
Montandon AJ, et al.
Hum Genet 85 : 200-204. 1990
53F9
DGGE detection of Hhal polymorphism in the F9 gene.
Caprino D, et al.
Nucleic Acids Res 18 : 4960. 1990
54F9
Identification of a factor IX point mutation using SSCP analysis and direct sequencing.
Demers DB, et al.
Nucleic Acids Res 18 : 5575. 1990
55F9
Direct detection of the deletion-insertion polymorphism of the factor IX gene by analysis of amplified DNA sequences (PCR).
Hanauer A, et al.
Thromb Res 59 : 219-220. 1990
56F9, DXS102, DXS400, DXS401, DXS402
Large-scale mapping and chromosome jumping in the q27 region of the human X chromosome.
Nguyen C, et al.
Genomics 5 : 298-303. 1989
57F9
Physical mapping of probes proximal to the fragile X locus (FRAX) confirms the order F9-DXS105 (cX55.7)-DXS98 (4D8)-FRAXA.
Sauer SM, et al.
Cytogenet Cell Genet 50 : 172-173. 1989
58F9
Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior.
Attree O, et al.
Genomics 4 : 266-272. 1989
59F9
Functionally important regions of the factor IX gene have a low rate of polymorphism and high rate of mutation in the dinucleotide CpG.
Koeberl DD, et al.
Am J Hum Genet 45 : 448-457. 1989
60F9
Molecular pathology of haemophilia B.
Green PM, et al.
EMBO J 8 : 1067-1072. 1989
61F9, MCF2
Deletion of the mcf.2 transforming gene in two hemophilia B inhibitor patients.
Blake DJ, et al.
(HGM10) Cytogenet Cell Genet 51 : 963. 1989
62F9
Factor IX(Portland) : a nonsense mutation (CGA to TGA) resulting in hemophilia B.
Chen SH, et al.
Am J Hum Genet 44 : 567-569. 1989
63F9
A codon 338 nonsense mutation in the factor IX gene in unrelated hemophilia B patients : factor IX(338-New York).
Driscoll MC, et al.
Blood 74 : 737-742. 1989
64F9
The use of DNA amplification for genetic counselling related diagnosis in haemophilia B.
Tsang TC, et al.
Thromb Haemost 61 : 343-347. 1989
65F9
Direct detection of point mutations by mismatch analysis : application to haemophilia B.
Montandon AJ, et al.
Nucleic Acids Res 17 : 3347-3358. 1989
66F8, F8D, F9
Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers.
Winship PR, et al.
Lancet I : 631-634. 1989
67F8, F8D, F9
The molecular genetics of hemophilia A and B in man: factor VIII and factor IX deficiency.
Antonarakis SE.
Adv Hum Genet 17 : 27-55. 1988
68F9
Hemophilia B Durham : a mutation in the first EGF-like domain of factor IX that is characterized by polymerase chain reaction.
Denton PH, et al.
Blood 72 : 1407-1411. 1988
69F9
Identification of a CpG mutation in the coagulation factor-IX gene by analysis of amplified DNA sequences.
Siguret V, et al.
Br J Haematol 70 : 411-416. 1988
70F9
A factor IX mutation, verified by direct genomic sequencing, causes haemophilia B by a novel mechanism.
Tsang TC, et al.
EMBO J 7 : 3009-3015. 1988
71F9, FRAXA, DXS102, DXS105, DXS119, DXS152, DXS115
Genetic mapping of the Xq27-q28 region : new RFLP markers useful for diagnostic applications in fragile-X and hemophilia-B families.
Arveiler B, et al.
Am J Hum Genet 42 : 380-389. 1988
72F9, MCF2, DXS400
Nullisomic deletion of the mcf.2 transforming gene in two haemophilia B patients.
Anson DS, et al.
EMBO J 7 : 2795-2799. 1988
73F9, FRAXA
The use of distal deletions of Xq to order loci between factor IX and the fragile X site (Xq27.3).
Schwartz C, et al.
(HGM9) Cytogenet Cell Genet 46 : 688. 1987
74DXS99, F9
A DNA marker closely linked to the factor IX (haemophilia B) gene.
Mulligan L, et al.
Hum Genet 75 : 381-383. 1987
75F9
X;autosome translocations in females with X-linked recessive diseases.
Vianna-Morgante AM, et al.
7th Int Congr Hum Genet I : 97. 1987
76F9
Two sisters with a distal deletion at the Xq26/Xq27 interface : DNA studies indicate that the gene locus for factor IX is present.
Schwartz C, et al.
Hum Genet 76 : 54-57. 1987
77F9
MspI polymorphic site within the factor IX gene.
Freedenberg DL, et al.
Hum Genet 76 : 262-264. 1987
78F9, MCF2
Large scale physical mapping in the q27 region of the human X chromosome : the coagulation factor IX gene and the mcf.2 transforming sequence are separated by at most 270 kilobase pairs and are surrounded by several 'HTF islands'.
Nguyen C, et al.
EMBO J 6 : 3285-3289. 1987
79DXS102, DXS107, DXS15, DXS51, DXS52, F8, F8D, F9, FRAXA
Linkage analysis using multiple Xq DNA polymorphisms in normal families, families with the fragile X syndrome, and other families with X linked conditions.
Connor JM, et al.
J Med Genet 24 : 14-22. 1987
80F9
A De novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B.
Vidaud M, et al.
Blood 68 : 961-963. 1986
81F9
Localization by in situ hybridization of the coagulation factor IX geneand of two polymorphic DNA probes with respect to the fragile X site.
Mattei MG, et al.
Hum Genet 69 : 327-331. 1985
82FRAXA, FRAXB, FRAXC, F9
Recombinaison entre le site fragile Xq27 et le gne du facteur IX de la coagulation.
Landoulsi A, et al.
Ann Genet 28 : 201-205. 1985
83DXS15, DXS52, F8, F8D, F9
The human genes for hemophilia A and hemophilia B flank the Xchromosome fragile site at Xq27.3.
Purrello M, et al.
EMBO J 4 : 725-729. 1985
84F9
Linkage and recombination between fragile X-linked mental retardation and the factor IX gene.
Warren ST, Glover TW, Davidson RL, Jagadeeswaran P.
Hum Genet 69(1):44-6. 1985
85F9
Fine assignment of the coagulation factor IX gene.
Buckle VJ, et al.
(HGM8) Cytogenet Cell Genet 40 : 593-594. 1985
86F9
A new MspI restriction fragment length polymorphism in the hemophilia B locus.
Camerino G, et al.
Hum Genet 71 : 79-81. 1985
87FRAXA, F9
Evidence against close linkage for fra(Xq) of Martin-Bell syndrome and for factor IX.
Zoll B, et al.
Hum Genet 71 : 122-126. 1985
88F9
Carrier detection in hemophilia B using two further intragenicrestriction fragment length polymorphisms.
Winship PR, et al.
Nucleic Acids Res 12 : 8861-8872. 1984
89F9
Regional localization on the human X chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus).
Camerino G, et al.
Proc Natl Acad Sci U S A 81 : 498-502. 1984
90DXS30, DXS32, DXS53, DXS54, DXS61, F9
Regional mapping of coagulation factor IX gene and of several unique DNA sequences on the human chromosome X.
Camerino G, et al.
(HGM7) Cytogenet Cell Genet 37 : 431-432. 1984
91F9
Linkage analysis of X-linked mental retardation with and without fragile-X using factor IX gene probe.
Choo KH, et al.
Lancet II : 349. 1984
92F9, FRAXA
Close linkage of fragile X-mental retardation syndrome to haemophilia B and transmission through a normal male.
Camerino G, et al.
Nature 306 : 701-704. 1983
93F9
Molecular cloning of the gene for human anti-haemophiliac factor IX.
Choo KH, et al.
Nature 299 : 178-180. 1982